|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
2
|
Oser MG, Niederst MJ, Sequist LV and
Engelman JA: Transformation from non-small-cell lung cancer to
small-cell lung cancer: molecular drivers and cells of origin.
Lancet Oncol. 16:e165–e172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zappa C and Mousa SA: Non-small cell lung
cancer: current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang M, Herbst RS and Boshoff C: Toward
personalized treatment approaches for non-small-cell lung cancer.
Nat Med. 27:1345–1356. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Li J, Kang R, Klionsky DJ and Tang
D: Ferroptosis: Machinery and regulation. Autophagy. 17:2054–2081.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirschhorn T and Stockwell BR: The
development of the concept of ferroptosis. Free Radic Biol Med.
133:130–143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Banerjee R, Bintee B, Manickasamy MK, Jha
S, Alqahtani MS, Abbas M, Goel A, Sethi G, Ma Z and Kunnumakkara
AB: The solute carrier family 11 transporters: A bridge between
iron homeostasis and tumor biology. Cell Commun Signal. 23:3322025.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li M, Yu X, Liu Y, Ouyang S, Wu L, Chen X,
Yu H, Chen H, Lian S, Li Z, et al: KRAS/ABHD17C/ALOX15B axis
promotes pancreatic cancer progression via ferroptosis evasion. Adv
Sci (Weinh). Jun 26–2025.(Epub ahead of print).
|
|
10
|
Hu X, Chang H, Guo Y, Yu L, Li J, Zhang B,
Zhao H, Xu J, Pan G, Zhang K, et al: Mori Folium ethanol extracts
induce ferroptosis and suppress gastric cancer progression by
inhibiting the AKT/GSK3β/NRF2 axis. Phytomedicine. 142:1567892025.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen H, Xiao N, Zhang C, Li Y, Zhao X,
Zhang R, Bai L, Kang Q, Wan J and Liu H: JMJD6 K375 acetylation
restrains lung cancer progression by enhancing METTL14/m6A/SLC3A2
axis mediated cell ferroptosis. J Transl Med. 23:2332025.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao L, Zhou X, Xie F and Zhang L, Yan H,
Huang J, Zhang C, Zhou F, Chen J and Zhang L: Ferroptosis in cancer
and cancer immunotherapy. Cancer Commun (Lond). 42:88–116. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang W, Guo Y, Qian Y, Liu X, Li G, Wang
J, Yang X, Wu M, Fan Y, Luo H, et al: Ferroptosis-inducing
compounds synergize with docetaxel to overcome chemoresistance in
docetaxel-resistant non-small cell lung cancer cells. Eur J Med
Chem. 276:1166702024. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Daum AK, Schlicker L, Schneider MA, Muley
T, Klingmüller U, Schulze A, Thomas M, Christopoulos P and Sültmann
H: Cancer-associated fibroblasts promote drug resistance in
ALK-driven lung adenocarcinoma cells by upregulating lipid
biosynthesis. Cancer Metab. 13:282025. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tai F, Zhai R, Ding K, Zhang Y, Yang H, Li
H, Wang Q, Cao Z, Ge C, Fu H, et al: Long non-coding RNA lung
cancer-associated transcript 1 regulates ferroptosis via
microRNA-34a-5p-mediated GTP cyclohydrolase 1 downregulation in
lung cancer cells. Int J Oncol. 64:642024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Lu W, Yin F, Zeng P, Li H and Huang
A: Overexpression of TNFSF11 reduces GPX4 levels and increases
sensitivity to ferroptosis inducers in lung adenocarcinoma. J
Transl Med. 22:3402024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Christie WW and Harwood JL: Oxidation of
polyunsaturated fatty acids to produce lipid mediators. Essays
Biochem. 64:401–421. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wiktorowska-Owczarek A, Berezińska M and
Nowak JZ: PUFAs: Structures, metabolism and functions. Adv Clin Exp
Med. 24:931–941. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reed A, Ichu TA, Milosevich N, Melillo B,
Schafroth MA, Otsuka Y, Scampavia L, Spicer TP and Cravatt BF:
LPCAT3 inhibitors remodel the polyunsaturated phospholipid content
of human cells and protect from ferroptosis. ACS Chem Biol.
17:1607–1618. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma XH, Liu JH, Liu CY, Sun WY, Duan WJ,
Wang G, Kurihara H, He RR, Li YF, Chen Y and Shang H:
ALOX15-launched PUFA-phospholipids peroxidation increases the
susceptibility of ferroptosis in ischemia-induced myocardial
damage. Signal Transduct Target Ther. 7:2882022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nielsen JE, Jensen LN and Krabbe K:
Hereditary haemochromatosis: A case of iron accumulation in the
basal ganglia associated with a parkinsonian syndrome. J Neurol
Neurosurg Psychiatry. 59:318–321. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang S, Liu L, Li X, Li Q, Wang Y and Feng
X: cDTL contributes to breast cancer progression through regulating
redox homeostasis via affecting the function of system xc. Biochem
Biophys Res Commun. 744:1511962025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu H, Chen Y, Jing L, Zhai C and Shen L:
The link between ferroptosis and cardiovascular diseases: A novel
target for treatment. Front Cardiovasc Med. 8:7109632021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Z, Yan Y, Qi C, Liu J, Li L and Wang
J: The role of ferroptosis in cardiovascular disease and its
therapeutic significance. Front Cardiovasc Med. 8:7332292021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Xin L, Xiang M, Shang C, Wang Y,
Wang Y, Cui X and Lu Y: The molecular mechanisms of ferroptosis and
its role in cardiovascular disease. Biomed Pharmacother.
145:1124232022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu Y, Jiang L, Wang H, Shen Z, Cheng Q,
Zhang P, Wang J, Wu Q, Fang X, Duan L, et al: Hepatic transferrin
plays a role in systemic iron homeostasis and liver ferroptosis.
Blood. 136:726–739. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mancias JD, Wang X, Gygi SP, Harper JW and
Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo
receptor mediating ferritinophagy. Nature. 509:105–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fang X, Ardehali H, Min J and Wang F: The
molecular and metabolic landscape of iron and ferroptosis in
cardiovascular disease. Nat Rev Cardiol. 20:7–23. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
CISD1 inhibits ferroptosis by protection against mitochondrial
lipid peroxidation. Biochem Biophys Res Commun. 478:838–844. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim EH, Shin D, Lee J, Jung AR and Roh JL:
CISD2 inhibition overcomes resistance to sulfasalazine-induced
ferroptotic cell death in head and neck cancer. Cancer Lett.
432:180–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sies H: Glutathione and its role in
cellular functions. Free Radic Biol Med. 27:916–921. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu G, Fang YZ, Yang S, Lupton JR and
Turner ND: Glutathione metabolism and its implications for health.
J Nutr. 134:489–492. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pompella A, Visvikis A, Paolicchi A, De
Tata V and Casini AF: The changing faces of glutathione, a cellular
protagonist. Biochem Pharmacol. 66:1499–1503. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Paul BD, Sbodio JI and Snyder SH: Cysteine
metabolism in neuronal redox homeostasis. Trends Pharmacol Sci.
39:513–524. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ursini F and Maiorino M: Lipid
peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic
Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Desideri E, Ciccarone F and Ciriolo MR:
Targeting glutathione metabolism: Partner in crime in anticancer
therapy. Nutrients. 11:19262019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu H, Forouhar F, Lin AJ, Wang Q,
Polychronidou V, Soni RK, Xia X and Stockwell BR: Small-molecule
allosteric inhibitors of GPX4. Cell Chem Biol. 29:1680–1693.e9.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Zhao Y, Wang H, Zhang C, Wang M,
Yang Y, Xu X and Hu Z: Histone demethylase KDM3B protects against
ferroptosis by upregulating SLC7A11. FEBS Open Bio. 10:637–643.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu J, Zhang C, Hu W and Feng Z: Tumor
suppressor p53 and metabolism. J Mol Cell Biol. 11:284–292. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kastenhuber ER and Lowe SW: Putting p53 in
Context. Cell. 170:1062–1078. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zille M, Karuppagounder SS, Chen Y, Gough
PJ, Bertin J, Finger J, Milner TA, Jonas EA and Ratan RR: Neuronal
death after hemorrhagic stroke in vitro and in vivo shares features
of ferroptosis and necroptosis. Stroke. 48:1033–1043. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kang R, Kroemer G and Tang D: The tumor
suppressor protein p53 and the ferroptosis network. Free Radic Biol
Med. 133:162–168. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hou MJ, Huang X and Zhu BT: Mechanism of
RSL3-induced ferroptotic cell death in HT22 cells: Crucial role of
protein disulfide isomerase. Acta Biochim Biophys Sin (Shanghai).
57:616–632. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Torres Á, Quintanilla F, Barnafi E,
Sánchez C, Acevedo F, Walbaum B and Merino T: Dietary interventions
for cancer prevention: An update to ACS international guidelines.
Nutrients. 16:28972024. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Huang Y, Cao D, Chen Z, Chen B, Li J, Guo
J, Dong Q, Liu L and Wei Q: Red and processed meat consumption and
cancer outcomes: Umbrella review. Food Chem. 356:1296972021.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mahabir S, Forman MR, Dong YQ, Park Y,
Hollenbeck A and Schatzkin A: Mineral intake and lung cancer risk
in the NIH-American association of retired persons diet and health
study. Cancer Epidemiol Biomarkers Prev. 19:1976–1983. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou W, Park S, Liu G, Miller DP, Wang LI,
Pothier L, Wain JC, Lynch TJ, Giovannucci E and Christiani DC:
Dietary iron, zinc, and calcium and the risk of lung cancer.
Epidemiology. 16:772–779. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Walter PB, Knutson MD, Paler-Martinez A,
Lee S, Xu Y, Viteri FE and Ames BN: Iron deficiency and iron excess
damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad
Sci USA. 99:2264–2269. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Altieri F, Grillo C, Maceroni M and
Chichiarelli S: DNA damage and repair: From molecular mechanisms to
health implications. Antioxid Redox Signal. 10:891–938. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wei Q, Cheng L, Amos CI, Wang LE, Guo Z,
Hong WK and Spitz MR: Repair of tobacco carcinogen-induced DNA
adducts and lung cancer risk: A molecular epidemiologic study. J
Natl Cancer Inst. 92:1764–1772. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ohno M, Miura T, Furuichi M, Tominaga Y,
Tsuchimoto D, Sakumi K and Nakabeppu Y: A genome-wide distribution
of 8-oxoguanine correlates with the preferred regions for
recombination and single nucleotide polymorphism in the human
genome. Genome Res. 16:567–575. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sung HK, Murugathasan M, Abdul-Sater AA
and Sweeney G: Autophagy deficiency exacerbates iron overload
induced reactive oxygen species production and apoptotic cell death
in skeletal muscle cells. Cell Death Dis. 14:2522023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shibata Y, Yasui H, Higashikawa K,
Miyamoto N and Kuge Y: Erastin, a ferroptosis-inducing agent,
sensitized cancer cells to X-ray irradiation via glutathione
starvation in vitro and in vivo. PLoS One. 14:e02259312019.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen G, Fillebeen C, Wang J and
Pantopoulos K: Overexpression of iron regulatory protein 1
suppresses growth of tumor xenografts. Carcinogenesis. 28:785–791.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen H, Zheng C, Zhang Y, Chang YZ, Qian
ZM and Shen X: Heat shock protein 27 downregulates the transferrin
receptor 1-mediated iron uptake. Int J Biochem Cell Biol.
38:1402–1416. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Jia Y, Dai J and Zeng Z: Potential
relationship between the selenoproteome and cancer. Mol Clin Oncol.
13:832020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhang J, Liu Y, Guo Y and Zhao Q: GPX8
promotes migration and invasion by regulating epithelial
characteristics in non-small cell lung cancer. Thorac Cancer.
11:3299–3308. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ishida T, Takahashi T, Kurokawa Y, Nishida
T, Hirota S, Serada S, Fujimoto M, Naka T, Teranishi R, Saito T, et
al: Targeted therapy for drug-tolerant persister cells after
imatinib treatment for gastrointestinal stromal tumours. Br J
Cancer. 125:1511–1522. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Deng S, Wu D, Li L, Liu T, Zhang T, Li J,
Yu Y, He M, Zhao YY, Han R and Xu Y: miR-324-3p reverses cisplatin
resistance by inducing GPX4-mediated ferroptosis in lung
adenocarcinoma cell line A549. Biochem Biophys Res Commun.
549:54–60. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Tang X, Ding H, Liang M, Chen X, Yan Y,
Wan N, Chen Q, Zhang J and Cao J: Curcumin induces ferroptosis in
non-small-cell lung cancer via activating autophagy. Thorac Cancer.
12:1219–1230. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yuan S, Xi S, Weng H, Guo MM, Zhang JH, Yu
ZP, Zhang H, Yu Z, Xing Z, Liu MY, et al: YTHDC1 as a tumor
progression suppressor through modulating FSP1-dependent
ferroptosis suppression in lung cancer. Cell Death Differ.
30:2477–2490. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Doll S, Freitas FP, Shah R, Aldrovandi M,
da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius
E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis
suppressor. Nature. 575:693–698. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chen YM, Lai CH, Lin CY, Tsai YH, Chang
YC, Chen HC, Tseng CC, Chang HC, Huang KT, Chen YC, et al: Body
mass index, weight loss, and mortality risk in advanced-stage
non-small cell lung cancer patients: A focus on EGFR mutation.
Nutrients. 13:37612021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhang T, Sun B, Zhong C, Xu K, Wang Z,
Hofman P, Nagano T, Legras A, Breadner D, Ricciuti B, et al:
Targeting histone deacetylase enhances the therapeutic effect of
Erastin-induced ferroptosis in EGFR-activating mutant lung
adenocarcinoma. Transl Lung Cancer Res. 10:1857–1872. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Binnewies M, Roberts EW, Kersten K, Chan
V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI,
Ostrand-Rosenberg S, Hedrick CC, et al: Understanding the tumor
immune microenvironment (TIME) for effective therapy. Nat Med.
24:541–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wen Q, Liu J, Kang R, Zhou B and Tang D:
The release and activity of HMGB1 in ferroptosis. Biochem Biophys
Res Commun. 510:278–283. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kagan VE, Mao G, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kim R, Taylor D, Vonderheide RH and
Gabrilovich DI: Ferroptosis of immune cells in the tumor
microenvironment. Trends Pharmacol Sci. 44:542–552. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Efimova I, Catanzaro E, Van der Meeren L,
Turubanova VD, Hammad H, Mishchenko TA, Vedunova MV, Fimognari C,
Bachert C, Coppieters F, et al: Vaccination with early ferroptotic
cancer cells induces efficient antitumor immunity. J Immunother
Cancer. 8:e0013692020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Tang D, Chen X, Kang R and Kroemer G:
Ferroptosis: Molecular mechanisms and health implications. Cell
Res. 31:107–125. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tang R, Xu J, Zhang B, Liu J, Liang C, Hua
J, Meng Q, Yu X and Shi S: Ferroptosis, necroptosis, and pyroptosis
in anticancer immunity. J Hematol Oncol. 13:1102020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Friedmann Angeli JP, Krysko DV and Conrad
M: Ferroptosis at the crossroads of cancer-acquired drug resistance
and immune evasion. Nat Rev Cancer. 19:405–414. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yu B, Choi B, Li W and Kim DH: Magnetic
field boosted ferroptosis-like cell death and responsive MRI using
hybrid vesicles for cancer immunotherapy. Nat Commun. 11:36372020.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Turubanova VD, Balalaeva IV, Mishchenko
TA, Catanzaro E, Alzeibak R, Peskova NN, Efimova I, Bachert C,
Mitroshina EV, Krysko O, et al: Immunogenic cell death induced by a
new photodynamic therapy based on photosens and photodithazine. J
Immunother Cancer. 7:3502019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Jiang C, Li X, Wan S, Ji S, Wang Q, Hu S,
Chen P, Wang B, Ge T, Zhang J, et al: Copper-doped polydopamine
nanoparticles-mediated GSH/GPX4-depleted ferroptosis and
cuproptosis sensitizes lung tumor to checkpoint blockade
immunotherapy. Small. 21:e25032082025. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Mao S, Li Q, Yang Y, Liu Z and Zhang L:
Potential crosstalk between ANXA1+ epithelial cells and FABP4+ TAM
cells of ferroptosis-related molecular clusters promotes an
immunosuppressive microenvironment in non-small cell lung cancer.
Mol Carcinog. 64:936–950. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Dai E, Han L, Liu J, Xie Y, Zeh HJ, Kang
R, Bai L and Tang D: Ferroptotic damage promotes pancreatic
tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway.
Nat Commun. 11:63392020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Veglia F, Tyurin VA, Mohammadyani D, Blasi
M, Duperret EK, Donthireddy L, Hashimoto A, Kapralov A, Amoscato A,
Angelini R, et al: Lipid bodies containing oxidatively truncated
lipids block antigen cross-presentation by dendritic cells in
cancer. Nat Commun. 8:21222017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Polonelli L, Dettori G, Morace G, Rosa R,
Castagnola M and Schipper MAA: Antigenic studies on Rhizopus
microsporus, Rh. rhizopodiformis, progeny and intermediates (Rh.
Chinensis). Antonie van Leeuwenhoek. 54:5–17. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Rothe T, Gruber F, Uderhardt S, Ipseiz N,
Rössner S, Oskolkova O, Blüml S, Leitinger N, Bicker W, Bochkov VN,
et al: 12/15-lipoxygenase-mediated enzymatic lipid oxidation
regulates DC maturation and function. J Clin Invest. 125:1944–1954.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ramakrishnan R, Tuyrin VA, Veglia F,
Condamine T, Amoscato A, Mohammadyani D, Johnson JJ, Zhang LM,
Klein-Seetharaman J, Celis E, et al: Oxidized lipids block antigen
cross-presentation by dendritic cells in cancer. J Immunol.
192:2920–2931. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Kapralov AA, Yang Q, Dar HH, Tyurina YY,
Anthonymuthu TS, Kim R, St Croix CM, Mikulska-Ruminska K, Liu B,
Shrivastava IH, et al: Redox lipid reprogramming commands
susceptibility of macrophages and microglia to ferroptotic death.
Nat Chem Biol. 16:278–290. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhao J, Dar HH, Deng Y, St Croix CM, Li Z,
Minami Y, Shrivastava IH, Tyurina YY, Etling E, Rosenbaum JC, et
al: PEBP1 acts as a rheostat between prosurvival autophagy and
ferroptotic death in asthmatic epithelial cells. Proc Natl Acad Sci
USA. 117:14376–14385. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lu Y, Yang H, Cao Y, Wang Y, Wu M, He B,
Xu J, Su Z, Luo W, Liu Y and Hu W: A survival model for prognostic
prediction based on ferroptosis-associated genes and the
association with immune infiltration in lung squamous cell
carcinoma. PLoS One. 18:e02828882023. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ouyang X, Zhu R, Lin L, Wang X, Zhuang Q
and Hu D: GAPDH Is a novel ferroptosis-related marker and
correlates with immune microenvironment in lung adenocarcinoma.
Metabolites. 13:1422023. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lei G, Zhang Y, Koppula P, Liu X, Zhang J,
Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H and Gan B: The role of
ferroptosis in ionizing radiation-induced cell death and tumor
suppression. Cell Res. 30:146–162. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Guan X, Yang Z, Wang J, Lu W, Wang S, Yang
M, Sun P, Hu W, Yang L and Li H: Naringin attenuates myocardial
ischemia-reperfusion injury by promoting mitochondrial
translocation of NDUFS1 and suppressing cardiac microvascular
endothelial cell ferroptosis. J Nutr Biochem. Jul 3–2025.(Epub
ahead of print). View Article : Google Scholar
|
|
95
|
Wang X, Liu T, Fei Y, Zhang S, Yang Y,
Chen Z, Zhu R, Deng S, Zhang T, Wu D and Xu Y: RTA-408 overcomes
cisplatin-resistant lung cancer by inhibiting WWP1-mediated NCOA4
ubiquitination to induce ferritinophagy and ferroptosis. Free
Radical Biol Med. 238:595–610. 2025.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Reichert CO, de Freitas FA, Sampaio-Silva
J, Rokita-Rosa L, Barros PL, Levy D and Bydlowski SP: Ferroptosis
mechanisms involved in neurodegenerative diseases. Int J Mol Sci.
21:87652020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zou P, He Q, Xia H and Zhong W:
Ferroptosis and its impact on common diseases. PeerJ.
12:e187082024. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Lu B, Chen XB, Ying MD, He QJ, Cao J and
Yang B: The role of ferroptosis in cancer development and treatment
response. Front Pharmacol. 8:9922018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Ge A, Xiang W, Li Y, Zhao D, Chen J, Daga
P, Dai CC, Yang K, Yan Y, Hao M, et al: Broadening horizons: The
multifaceted role of ferroptosis in breast cancer. Front Immunol.
15:14557412024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Wang L, Chen X and Yan C: Ferroptosis: An
emerging therapeutic opportunity for cancer. Genes Dis. 9:334–346.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Pei M, Guan X, Hou X, Niu Z, Lyu Q, Wang
K, Wang S, Zhang J, Ke Y, Zhuang S, et al: A GSH-consuming
polymeric nanoparticles drives ferroptosis amplification and
combines chemotherapy to amplify breast cancer treatment. J
Nanobiotechnol. 23:4972025. View Article : Google Scholar
|
|
102
|
Chen X, Cui H, Qin L, Liu R, Fang F and
Wang Z: Soybean lecithin-gallic acid complex sensitizes lung cancer
cells to radiation through ferroptosis regulated by
Nrf2/SLC7A11/GPX4 pathway. Nutrients. 17:12622025. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhang T, Gu F, Lin W, Shao H, Jiang A and
Guan X: Boosting cancer immunotherapy: Drug delivery systems
leveraging ferroptosis and immune checkpoint blockade. Front
Immunol. 16:16112992025. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Feng S, Li Y, Huang H, Huang H, Duan Y,
Yuan Z, Zhu W, Mei Z, Luo L and Yan P: Isoorientin reverses lung
cancer drug resistance by promoting ferroptosis via the
SIRT6/Nrf2/GPX4 signaling pathway. Eur J Pharmacol. 954:1758532023.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Li Y, Yan H, Xu X, Liu H, Wu C and Zhao L:
Erastin/sorafenib induces cisplatin-resistant non-small cell lung
cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.
Oncol Lett. 19:323–333. 2020.PubMed/NCBI
|
|
106
|
Yan WY, Cai J, Wang JN, Gong YS and Ding
XB: Co-treatment of betulin and gefitinib is effective against EGFR
wild-type/KRAS-mutant non-small cell lung cancer by inducing
ferroptosis. Neoplasma. 69:648–6569. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yu J, Zhong B, Zhao L, Hou Y, Ai N, Lu JJ,
Ge W and Chen X: Fighting drug-resistant lung cancer by induction
of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis.
Drug Resist Updat. 70:1009772023. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Lin Q, Hou S, Dai Y, Jiang N and Lin Y:
Monascin exhibits neuroprotective effects in rotenone model of
Parkinson's disease via antioxidation and anti-neuroinflammation.
Neuroreport. 31:637–643. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Yin L, Liu P, Jin Y, Ning Z, Yang Y and
Gao H: Ferroptosis-related small-molecule compounds in cancer
therapy: Strategies and applications. Eur J Med Chem.
244:1148612022. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Koeberle SC, Kipp AP, Stuppner H and
Koeberle A: Ferroptosis-modulating small molecules for targeting
drug-resistant cancer: Challenges and opportunities in manipulating
redox signaling. Med Res Rev. 43:614–682. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Shimada K, Skouta R, Kaplan A, Yang WS,
Hayano M, Dixon SJ, Brown LM, Valenzuela CA, Wolpaw AJ and
Stockwell BR: Global survey of cell death mechanisms reveals
metabolic regulation of ferroptosis. Nat Chem Biol. 12:497–503.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Golbashirzadeh M, Heidari HR, Talebi M and
Yari Khosroushahi A: Ferroptosis as a potential cell death
mechanism against cisplatin-resistant lung cancer cell line. Adv
Pharm Bull. 13:176–187. 2023.PubMed/NCBI
|
|
113
|
Zhang X, Sui S, Wang L, Li H, Zhang L, Xu
S and Zheng X: Inhibition of tumor propellant glutathione
peroxidase 4 induces ferroptosis in cancer cells and enhances
anticancer effect of cisplatin. J Cell Physiol. 235:3425–3437.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wang J, Cheng CS, Lu Y, Ding X, Zhu M,
Miao C and Chen J: Novel findings of anti-cancer property of
propofol. Anticancer Agents Med Chem. 18:156–165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Gu L, Pan X, Wang C and Wang L: The
benefits of propofol on cancer treatment: Decipher its modulation
code to immunocytes. Front Pharmacol. 13:9196362022. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Huang Y, Lei L and Liu Y: Propofol
improves sensitivity of lung cancer cells to cisplatin and its
mechanism. Med Sci Monit. 26:e9197862020.PubMed/NCBI
|
|
117
|
Ling Q, Wu S, Liao X, Liu C and Chen Y:
Anesthetic propofol enhances cisplatin-sensitivity of non-small
cell lung cancer cells through N6-methyladenosine-dependently
regulating the miR-486-5p/RAP1-NF-κB axis. BMC Cancer. 22:7652022.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Quan Y, Li S, Wang Y, Liu G, Lv Z and Wang
Z: Propofol and sevoflurane alleviate malignant biological behavior
and cisplatin resistance of xuanwei lung adenocarcinoma by
modulating the Wnt/β-catenin pathway and PI3K/AKT pathway.
Anticancer Agents Med Chem. 22:2098–2108. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao
Q, Chen C, Qi Y, Gao W, He W, et al: RBMS1 regulates lung cancer
ferroptosis through translational control of SLC7A11. J Clin
Invest. 131:e1520672021. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Suzuki K, Yamamoto J, Toh K and Miyaoka R:
5-aminiolevulinic acid induces a radiodynamic effect with enhanced
delayed reactive oxygen species production under hypoxic conditions
in lymphoma cells: An in vitro study. Exp Ther Med. 26:3602023.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Kim S, Jin HO, Jang SK, Ahn SH, Kim G, Kim
H, Lee TG, Kim CH and Park IC: Iron overload enhances the
susceptibility to cysteine deprivation-induced ferroptosis in
non-small cell lung cancer cells. Med Oncol. 42:2012025. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Liu X, He J, Ying H, Chen C, Zheng C, Luo
P, Zhu W, Wei T, Tang B and Zhang J: Targeting PFKFB4 biomimetic
codelivery system synergistically enhances ferroptosis to suppress
small cell lung cancer and augments the efficacy of anti-PD-L1
immunotherapy. Adv Sci (Weinh). 12:e24173742025. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Neitzel LR, Fuller DT, Cornell J, Rea S,
de Aguiar Ferreira C, Williams CH and Hong CC: Inhibition of GPR68
induces ferroptosis and radiosensitivity in diverse cancer cell
types. Sci Rep. 15:40742025. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Koppula P, Lei G, Zhang Y, Yan Y, Mao C,
Kondiparthi L, Shi J, Liu X, Horbath A, Das M, et al: A targetable
CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1
inactive lung cancers. Nat Commun. 13:22062022. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Aubrun C, Doussineau T, Carmès L, Meyzaud
A, Boux F, Dufort S, Delfour A, De Beaumont O, Mirjolet C and Le
Duc G: Mechanisms of action of AGuIX as a pan-cancer
nano-radiosensitizer: A comprehensive review. Pharmaceuticals
(Basel). 18:5192025. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Aishajiang R, Liu Z, Liang Y, Du P, Wei Y,
Zhuo X, Liu S, Lei P, Wang T and Yu D: Concurrent amplification of
ferroptosis and immune system activation via nanomedicine-mediated
radiosensitization for triple-negative breast cancer therapy. Adv
Sci (Weinh). 12:e24078332025. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Han Z, Wang Y, Zang X, Liu H, Su J and
Zhou Y: FePt/MnO2@PEG nanoparticles as multifunctional
radiosensitizers for enhancing ferroptosis and alleviating hypoxia
in osteosarcoma therapy. IEEE Trans Nanobioscience. 24:180–190.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Zhang Y, Liu X, Zeng L, Zhao X, Chen Q,
Pan Y, Bai Y, Shao C and Zhang J: Exosomal protein
angiopoietin-like 4 mediated radioresistance of lung cancer by
inhibiting ferroptosis under hypoxic microenvironment. Br J Cancer.
127:1760–1772. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Salomone F, Nuccio A and Ferrara R:
PD-L1-overexpressing NSCLC: Overcoming all-comer approach and
network effect to weather the ‘winter’ of cancer immunotherapy. J
Thorac Oncol. 20:834–838. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Marrone MT, Reuss JE, Crawford A, Neelon
B, Liu JO, Brahmer JR and Platz EA: Statin use with immune
checkpoint inhibitors and survival in nonsmall cell lung cancer.
Clin Lung Cancer. 26:201–209. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei
Y, Chang SS, Yamaguchi H, Lee HH, Ke B, et al: TYRO3 induces
anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and
tumoral ferroptosis. J Clin Invest. 131:e1394342021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Mao W, Cai Y, Chen D, Jiang G, Xu Y, Chen
R, Wang F, Wang X, Zheng M, Zhao X and Mei J: Statin shapes
inflamed tumor microenvironment and enhances immune checkpoint
blockade in non-small cell lung cancer. JCI Insight. 7:e1619402022.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Zhao YY, Yang YQ, Sheng HH, Tang Q, Han L,
Wang SM and Wu WY: GPX4 plays a crucial role in fuzheng kang'ai
decoction-induced non-small cell lung cancer cell ferroptosis.
Front Pharmacol. 13:8516802022. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Wang W, Green M, Choi JE, Gijón M, Kennedy
PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al: CD8+ T
cells regulate tumour ferroptosis during cancer immunotherapy.
Nature. 569:270–274. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Zheng Y, Sun L, Guo J and Ma J: The
crosstalk between ferroptosis and anti-tumor immunity in the tumor
microenvironment: molecular mechanisms and therapeutic controversy.
Cancer Commun (Lond). 43:1071–1096. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Alavinejad M, Shirzad M, Javid-Naderi MJ,
Rahdar A, Fathi-karkan S and Pandey S: Smart nanomedicines powered
by artificial intelligence: A breakthrough in lung cancer diagnosis
and treatment. Med Oncol. 42:1342025. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Yadav B, Chauhan M, Singh RP, Sonali and
Shekhar S: Recent progress and challenges in clinical translation
of nanomedicines in diagnosis and treatment of lung cancer. Curr
Drug Targets. 25:12–24. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Yao X, Yang P, Jin Z, Jiang Q, Guo R, Xie
R, He Q and Yang W: Multifunctional nanoplatform for photoacoustic
imaging-guided combined therapy enhanced by CO induced ferroptosis.
Biomaterials. 197:268–283. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Wei F, Ke L, Gao S, Karges J, Wang J, Chen
Y, Ji L and Chao H: In situ oxidative polymerization of
platinum(iv) prodrugs in pore-confined spaces of
CaCO3nanoparticles for cancer chemoimmunotherapy. Chem
Sci. 14:7005–7015. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Zhu G, Chi H, Liu M, Yin Y, Diao H, Liu Z,
Guo Z, Xu W, Xu J, Cui C, et al: Multifunctional ‘ball-rod’ Janus
nanoparticles boosting Fenton reaction for ferroptosis therapy of
non-small cell lung cancer. J Colloid Interface Sci. 621:12–23.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Wang J, Yang W, He X, Zhang Z and Zheng X:
Assembling p53 activating peptide with CeO2 nanoparticle to
construct a metallo-organic supermolecule toward the synergistic
ferroptosis of tumor. Front Bioeng Biotechnol. 10:9295362022.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Li Y, Yang J, Gu G, Guo X, He C, Sun J,
Zou H, Wang H, Liu S, Li X, et al: Pulmonary delivery of
theranostic nanoclusters for lung cancer ferroptosis with enhanced
chemodynamic/radiation synergistic therapy. Nano Lett. 22:963–972.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Tarangelo A, Magtanong L, Bieging-Rolett
KT, Li Y, Ye J, Attardi LD and Dixon SJ: p53 suppresses metabolic
stress-induced ferroptosis in cancer cells. Cell Rep. 22:569–575.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Liu J, Zhang C, Wang J, Hu W and Feng Z:
The Regulation of ferroptosis by tumor suppressor p53 and its
pathway. Int J Mol Sci. 21:83872020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Song MY, Lee DY, Chun KS and Kim EH: The
role of NRF2/KEAP1 signaling pathway in cancer metabolism. Int J
Mol Sci. 22:43762021. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M,
Buchfelder M and Savaskan N: Nrf2-Keap1 pathway promotes cell
proliferation and diminishes ferroptosis. Oncogenesis. 6:e3712017.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Zhang L, Wang H, Liang B, Qin L, Zhang M,
Lv X, Hu S, Fan X, Xie W, Yang H, et al: Ponicidin promotes
ferroptosis to enhance treatment sensitivity in
Lenvatinib-resistant hepatocellular carcinoma cells through
regulation of KEAP1/NRF2. Phytomedicine. 143:1568242025. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Wang L, Wu S, He H, Ai K, Xu R, Zhang L
and Zhu X: CircRNA-ST6GALNAC6 increases the sensitivity of bladder
cancer cells to erastin-induced ferroptosis by regulating the
HSPB1/P38 axis. Lab Invest. 102:1323–1334. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Liang Z, Zhao W, Li X, Wang L, Meng L and
Yu R: Cisplatin synergizes with PRLX93936 to induce ferroptosis in
non-small cell lung cancer cells. Biochem Biophys Res Commun.
569:79–85. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wang H, Cheng Y, Mao C, Liu S, Xiao D,
Huang J and Tao Y: Emerging mechanisms and targeted therapy of
ferroptosis in cancer. Mol Ther. 29:2185–2208. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Chen X, Zhang L, He Y, Huang S, Chen S,
Zhao W and Yu D: Regulation of m6A modification on ferroptosis and
its potential significance in radiosensitization. Cell Death
Discov. 9:3432023. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Kitakata H, Endo J, Matsushima H, Yamamoto
S, Ikura H, Hirai A, Koh S, Ichihara G, Hiraide T, Moriyama H, et
al: MITOL/MARCH5 determines the susceptibility of cardiomyocytes to
doxorubicin-induced ferroptosis by regulating GSH homeostasis. J
Mol Cell Cardiol. 161:116–129. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Maniam P, Essilfie AT, Kalimutho M, Ling
D, Frazer DM, Phipps S, Anderson GJ and Reid DW: Increased
susceptibility of cystic fibrosis airway epithelial cells to
ferroptosis. Biol Res. 54:382021. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Saha S, Skeie JM, Schmidt GA, Eggleston T,
Shevalye H, Sales CS, Phruttiwanichakun P, Dusane A, Field MG,
Rinkoski TA, et al: TCF4 trinucleotide repeat expansions and UV
irradiation increase susceptibility to ferroptosis in Fuchs
endothelial corneal dystrophy. Redox Biol. 77:1033482024.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Yan H, Tuo Q and Lei P: Cell density
impacts the susceptibility to ferroptosis by modulating
IRP1-mediated iron homeostasis. J Neurochem. 168:1359–1373. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Tahayneh K, Idkedek M and Abu Akar F:
NSCLC: Current evidence on its pathogenesis, integrated treatment,
and future perspectives. J Clin Med. 14:10252025. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Pandjarova I, Mercieca D, Gijtenbeek RGP,
Pereira JO, Fantin A, Castaldo N, Keramida E, Pannu K, Konsoulova A
and Aujayeb A: Small cell lung cancer and neuroendocrine tumours.
Breathe (Sheff). 20:2400042024. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Yang WS and Stockwell BR: Ferroptosis:
Death by lipid peroxidation. Trends Cell Biol. 26:165–176. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li
Y and Peng Z: ROS-induced lipid peroxidation modulates cell death
outcome: Mechanisms behind apoptosis, autophagy, and ferroptosis.
Arch Toxicol. 97:1439–1451. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Cui S, Ghai A, Deng Y, Li S, Zhang R,
Egbulefu C, Liang G, Achilefu S and Ye J: Identification of
hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic
damage in chronic liver diseases. Mol Cell. 83:3931–3939.e5. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Kwon OS, Kwon EJ, Kong HJ, Choi JY, Kim
YJ, Lee EW, Kim W, Lee H and Cha HJ: Systematic identification of a
nuclear receptor-enriched predictive signature for erastin-induced
ferroptosis. Redox Biol. 37:1017192020. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Su Y, Zhao B, Zhou L, Zhang Z, Shen Y, Lv
H, AlQudsy LHH and Shang P: Ferroptosis, a novel pharmacological
mechanism of anti-cancer drugs. Cancer Lett. 483:127–136. 2020.
View Article : Google Scholar : PubMed/NCBI
|
